ETF that equally weights S&P 500 stocks climbs in broad market rally this week
A gauge of the U.S. equities market that equally weights stocks in the S&P 500 index was up again Friday, as the market continued its broad rally this week. The Invesco S&P 500 Equal Weight ETF was ...
Novo Nordisk Says Higher-Dose Wegovy Achieves Greater Weight Loss in Trial — Update
Novo Nordisk said that patients taking a higher dose of its blockbuster Wegovy obesity shot lost more weight than those on a lower dose without experiencing an increase in side-effects, according to a ...
Nasdaq, S&P, Dow up, with Wall Street set for best week since November
U.S. equity market averages advanced Friday, drawing Wall Street toward its best week since the 2024 election, with stocks ...
Novo Nordisk's Wegovy Achieves Weight-Loss of 20.7% at Higher Dose, Study Says
The late-stage trial of semaglutide, which it markets as Wegovy to treat obesity, showed that those who took a dose of 7.2 milligrams lost an average of 20.7% of their weight over 72 weeks. A third of ...
Performance Insights: The S&P 500 Equal Weight ESG Index
Since its launch in July 2022 to year-end 2024, the S&P 500 Equal Weight ESG Index achieved a cumulative outperformance of 0.86% compared to its benchmark, the S&P 500 Equal Weight Index.
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The drugs account for $41 billion in annual Medicare spending, the Biden administration said.